These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38375849)

  • 1. Advanced Targeted Drug Delivery of Bioactive Nanomaterials in the Management of Cancer.
    Basu B; Garala KK; Patel R; Dutta A; Ash D; Prajapati B; Singh S; Jha SK
    Curr Med Chem; 2024 Feb; ():. PubMed ID: 38375849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment.
    Jain V; Jain S; Mahajan SC
    Curr Drug Deliv; 2015; 12(2):177-91. PubMed ID: 25146439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes.
    Wakaskar RR
    J Drug Target; 2018 Apr; 26(4):311-318. PubMed ID: 28797169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective Cancer Management: Inimitable Role of Phytochemical Based Nano- Formulations.
    Upaganlawar A; Polshettiwar S; Raut S; Tagalpallewar A; Pande V
    Curr Drug Metab; 2022; 23(11):869-881. PubMed ID: 36065928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances of Nanotechnology in the Diagnosis and Therapy of Triple- Negative Breast Cancer (TNBC).
    Kanugo A; Gautam RK; Kamal MA
    Curr Pharm Biotechnol; 2022; 23(13):1581-1595. PubMed ID: 34967294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactive Loaded Novel Nano-Formulations for Targeted Drug Delivery and Their Therapeutic Potential.
    Kumari S; Goyal A; Sönmez Gürer E; Algın Yapar E; Garg M; Sood M; Sindhu RK
    Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Science and technology of the emerging nanomedicines in cancer therapy: A primer for physicians and pharmacists.
    Pillai G; Ceballos-Coronel ML
    SAGE Open Med; 2013; 1():2050312113513759. PubMed ID: 26770691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Delivery of Drugs and Genes Using Polymer Nanocarriers for Cancer Therapy.
    Xia W; Tao Z; Zhu B; Zhang W; Liu C; Chen S; Song M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer- and liposome-based nanoparticles in targeted drug delivery.
    Venkatraman SS; Ma LL; Natarajan JV; Chattopadhyay S
    Front Biosci (Schol Ed); 2010 Jun; 2(3):801-14. PubMed ID: 20515826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicines: A Focus on Nanomaterials as Drug Delivery System with Current Trends and Future Advancement.
    Pandey J; Dubey R; Kate A; Prasad B; Sinha A; Mishra MS
    Drug Res (Stuttg); 2022 Sep; 72(7):355-366. PubMed ID: 35636435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
    Narang AS; Chang RK; Hussain MA
    J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Threatening cancer with nanoparticle aided combination oncotherapy.
    Rawal S; Patel MM
    J Control Release; 2019 May; 301():76-109. PubMed ID: 30890445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomaterials: an intra-periodontal pocket drug-delivery system for periodontitis.
    Kumaar NR; Nair SC
    Ther Deliv; 2023 Mar; 14(3):227-249. PubMed ID: 37291865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future directions of liposome- and immunoliposome-based cancer therapeutics.
    Park JW; Benz CC; Martin FJ
    Semin Oncol; 2004 Dec; 31(6 Suppl 13):196-205. PubMed ID: 15717745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology Integrated Innovative Drug Delivery and Therapy for Cancer.
    Macadangdang RR; Agrawal R; Bhushan B; Garg A; Singh K; Kumar S; Kumar A
    Curr Pharm Biotechnol; 2024 Apr; ():. PubMed ID: 38716551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology for Targeted Drug Delivery to Treat Osteoporosis.
    Kaur M; Nagpal M; Aggarwal G
    Curr Drug Targets; 2023; 24(1):2-12. PubMed ID: 36200208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioluminescent nanoparticles for radiation-controlled release of drugs.
    Misra R; Sarkar K; Lee J; Pizzuti VJ; Lee DS; Currie MP; Torregrosa-Allen SE; Long DE; Durm GA; Langer MP; Elzey BD; Won YY
    J Control Release; 2019 Jun; 303():237-252. PubMed ID: 31026550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.